Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Akums Drugs and Pharmaceuticals is a contract development and manufacturing organisation (CDMO) producing finished formulations — tablets, capsules, liquids, injectables and more — for most large Indian pharma brands, alongside a smaller branded formulations and API business of its own. Its Haridwar-centred plants give it scale in domestic-market CDMO supply, and it listed via IPO in August 2024. Revenue is driven by CDMO volumes and new dosage capabilities.
India's largest domestic-focused pharmaceutical CDMO by volume of formulations produced.
Akums Drugs and Pharmaceuticals Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Akums Drugs and Pharmaceuticals Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
Per-share figures are not restated. Shares outstanding changed from 0.00 crore to 15.31 crore in FY26, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY26 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.
| Metric | FY26 | FY25 |
|---|---|---|
| EPS (basic, ₹) | 16.67 | 22.60 |
| Book value / share (₹) | 217.57 | 30,17,881.45 |
| Return on equity | 7.7% | 11.0% |
| Return on capital employed | 8.4% | 9.7% |
| Operating margin | 8.4% | 7.5% |
| Net margin | 5.9% | 8.3% |
| EBITDA | ₹522 Cr | ₹464 Cr |
| Free cash flow | ₹951 Cr | ₹193 Cr |
| Total debt | ₹73 Cr | ₹14 Cr |
| Debt to equity | 0.02 | 0.00 |
| Interest coverage | 3.9 | 9.0 |
| Current ratio | 3.25 | 2.55 |
| Shares outstanding | 15,31,05,000 | 10,152 |
Open the full income statement, balance sheet and cash flow for AKUMS →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.